Not applicableStudy completedNCT02325921What this trial is testingMRI in Renal TumorsWho this might be right forRenal Cell Carcinoma Radboud University Medical Center 39
Testing effectiveness (Phase 2)Ended earlyNCT02273752What this trial is testingPharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerWho this might be right forEstrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more Emory University 2
Not applicableStudy completedNCT04933604What this trial is testingLPN in Patients With High-complex Renal TumorsWho this might be right forRenal CancerRenal NeoplasmRenal Cell Carcinoma+7 more Samsun Liv Hospital 78
Testing effectiveness (Phase 2)Looking for participantsNCT07386158What this trial is testingPucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCCWho this might be right forVorolanibClear Cell Renal Cell Carcinoma (ccRCC)Neoadjuvant Therapy Sun Yat-sen University 21
Testing effectiveness (Phase 2)Study completedNCT01538238What this trial is testingPazopanib_NCRCC,Ph2 STUDYWho this might be right forLocally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma Samsung Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00017329What this trial is testingPS-341 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00032188What this trial is testingInterleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 65
Large-scale testing (Phase 3)Study completedNCT00002473What this trial is testingKidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC
Not applicableUnknownNCT03226886What this trial is testingTRACERx Renal CAPTURE Sub-studyWho this might be right forRenal Cell CarcinomaCancerHealthy Volunteers Royal Marsden NHS Foundation Trust 360
Not applicableStudy completedNCT00073879What this trial is testingFludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationWho this might be right forKidney Cancer Baylor College of Medicine
Not applicableUnknownNCT06391879What this trial is testingEstablishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell CarcinomaWho this might be right forVHL SyndromeRenal Cell Carcinoma Peking University First Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01798446What this trial is testingA Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With TemsirolimusWho this might be right forRenal Cell CarcinomaNonclear CellTemsirolimus Resistance Seoul National University Hospital 41
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Early research (Phase 1)Looking for participantsNCT07187869What this trial is testingModulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept StudyWho this might be right forClear Cell Renal Cell Carcinoma M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00003551What this trial is testingAminocamptothecin in Treating Patients With Advanced or Recurrent Kidney CancerWho this might be right forKidney Cancer Emory University
Not applicableNo Longer AvailableNCT06090331What this trial is testing89Zr-DFO-girentuximab Expanded Access Program (EAP)Who this might be right forClear Cell Renal Cell Carcinoma Telix Pharmaceuticals (Innovations) Pty Limited
Testing effectiveness (Phase 2)WithdrawnNCT02763761What this trial is testingAn Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or OpdivoWho this might be right forRenal Cell CarcinomaMelanomaLung Cancer Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT06889649What this trial is testingSABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCCWho this might be right forRadiation TherapyTargeted TherapyImmunotherapy+1 more Peking University First Hospital 30
Early research (Phase 1)Study completedNCT02386826What this trial is testingINC280 Combined With Bevacizumab in Patients With Glioblastoma MultiformeWho this might be right forGlioblastoma MultiformeGliosarcomaColorectal Cancer+1 more SCRI Development Innovations, LLC 65
Testing effectiveness (Phase 2)Study completedNCT02724878What this trial is testingStudy of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Non-Clear Cell Kidney Cancer Dana-Farber Cancer Institute 65